OR AKIVA, Israel, SHANGHAI and SAO PAULO, Nov. 16, 2015 /PRNewswire/ --
CNOGA's new mobile app and CNOGA's secure cloud-based architecture, Singular, enable patient-caretaker connectivity, improving patient's quality of life.
CNOGA Medical Ltd., a privately held international company, will present its non-invasive devices, groundbreaking secure cloud-based platform and mobile application at MEDICA 2015, the world's largest annual medical trade fair in Dusseldorf, Germany, November 16-19, 2015. CNOGA, is one of the first worldwide developers and manufacturers of non-invasive, pain-free medical measurement devices for various medical conditions including diabetes, hypertension, respiratory cardiovascular and other disease, aimed at improving patient quality of life. The company's new Singular platform enables connectivity between the patient's non-invasive TensorTip™ medical measurement devices through a secure cloud-based platform and mobile application to their caregivers and physicians, friends and family. CNOGA's easy-to-use, portable devices are designed for both personal as well as professional use and comply with the highest accuracy standards and quality requirements.
A unique product line with groundbreaking options:
CNOGA TensorTip™ devices are portable, lightweight and easy to use. The technology uses a real time color image sensor and unique algorithms to enable the analysis of a vast amount of data in detecting blood chromatic changes of diabetes and cardiovascular patients painlessly. Once the patient places one finger in the finger compartment, the device automatically measures and displays more than a dozen blood parameters. If desired, the patient can easily transmit the results via bluetooth connectivity to any mobile device or PC and share them with medical professionals and caretakers to control his or her health remotely. A built-in memory function can store monitored results in the device itself for physician review.
About CNOGA Noninvasive devices
CNOGA Tensortip™ Matrix™ (MTX) securely measures, monitors and analyzes more than a dozen blood parameters non-invasively - Blood pressure, Stroke Volume, Cardiac Output, Cardiac Index, as well as Blood Gases (CO2, O2, pH), Hemoglobin, Hematocrit, Red Blood Cell, Pulse and Main Atrial Blood Pressure and more.
CNOGA Tensortip™ Combo Glucometer (CoG) provides a revolutionary, painless and non-invasive approach to glucose measurement, enabling diabetics to monitor their glucose levels everywhere with no prick and no blood. This device is individually calibrated for each patient and is designed for everyday use.
CNOGA Tensortip™ VSM™ tracks Blood Pressure, Oxygen Saturation and Pulse per Minute and offers, like all CNOGA devices, non-invasive and ease-of-use measurements.
CNOGA Singular is CNOGA's secure cloud infrastructure, designed to safely transfer medical results from the devices to CNOGA's mobile application and allows secure access to caretakers, physicians or other selected stakeholders.
About CNOGA Medical Ltd.:
CNOGA Medical Ltd., an international privately held company, is a leading developer and manufacturer of innovative, non-invasive, pain-free medical devices for personal use, as well as professional remote medical care.
Headquartered in Israel, and subsidiaries in Shanghai, China and Sao-Paulo, Brazil, the company was founded in 2004 by Dr. Yosef Segman, a technology innovator and entrepreneur, who has led product development from the early stages through a strategic partnership with Texas Instruments Inc., to commercialization in Europe, Asia and South America. The company's Medical Advisor is Prof. Eli Zuckermann, who is with the Faculty of Medicine at the Technion, the Israel Institute of Technology.
CNOGA Medical is pursuing a future in which people conduct simple, needle-free blood tests in the comfort of their own homes or other locations. CNOGA's systems have undergone extensive clinical trials, are registered to ISO13485:2003 and are being commercialized in Europe, Asia and South America. The devices have been CE certified as a 2a Medical Device since May 2014 and the company has received FDA approval for marketing the blood pressure and pulse (PPM) devices.
Press Contacts:
CNOGA Medical Ltd.
Dr. Yosef Segman anat@CNOGA.com
Mr. Alon Kapel alon@ CNOGA.com
22 Hailan Street North Industrial Park
3065101 Or Akiva, Israel
Tel: +972-4-6361080
http://www.CNOGA.com
Lucy Turpin Communications GmbH
Eva Hildebrandt
E.Hildebrandt@lucyturpin.com
PR & MarCom Director
Prinzregentenstrasse 79
81675 Munich, Germany
Tel: +49-89-417761-14
Mobil: +49-151-25-36-9887
http://www.lucyturpin.com
